Pharnext SA
PAR:ALPHA
During the last 3 months Pharnext SA insiders have not bought any shares, and have not sold any shares.
The last transaction was made on
Apr 30, 2024
by
N.d.k Société Par Actions Simplifiées Personne Morale Liée ?
, who
bought
44m EUR
worth of 
ALPHA shares.
During the last 3 months Pharnext SA insiders have not bought any shares, and have not sold any shares.
The last transaction was made on
Apr 30, 2024
by
N.d.k Société Par Actions Simplifiées Personne Morale Liée ?
, who
bought
44m EUR
worth of ALPHA shares.
Pharnext SA
Glance View
Pharnext SA develops and manufactures drugs for neurological diseases. The company is headquartered in Issy-Les-Moulineaux, Ile-De-France. The company went IPO on 2016-07-18. The firm is focused on discovering, developing and licensing new therapeutic solutions (Pleodrugs) and companion tests for unmet medical needs (large and niche markets) by using the Pleotherapy approach. Pharnext SA runs all its own activities, from research through to clinical development (no further than the end of Phase II trials), and then licenses the Pleodrugs to industrial partners. The firm's prime focus is on neurodegenerative diseases and metabolic diseases.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
